Skip to content
    Cantos logo

    Cantos

    San Francisco, California, United StatesFounded 2016

    Cantos is a pre-seed and seed venture capital firm that backs deeply technical founders building 'near frontier' companies across climate, biotech, aerospace, defense, and advanced manufacturing. The firm provides initial capital and ongoing counsel to founders tackling critical infrastructure and existential challenges.

    Average disclosed round size is $25.3M (across 47 rounds with reported amounts).

    Find people at Cantos on Goldilocks AI

    Portfolio

    36

    Fund Size

    $50M

    Top Stage

    Seed

    Last 12 Mo

    5

    Team

    Ian Rountree

    Ian Rountree

    General Partner | SF

    Grant Gregory

    Grant Gregory

    Partner | LA

    Amee Kapadia

    Amee Kapadia

    Principal | SF

    Sofia Garcia

    Sofia Garcia

    CFO | SF

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    51 investments
    CompanyRoundAmountDate
    HHeaviside IndustriesSeries B$60MAug 2026
    HHeaviside IndustriesSeries A$28MMay 2026
    Heaviside logoHeavisideSeries B$60MJan 2026
    Faeth Therapeutics logoFaeth TherapeuticsUnknown$25MOct 2025
    Adaptyx Biosciences logoAdaptyx BiosciencesSeed$14MOct 2025
    AAdaptyxSeed$14MOct 2025
    Moldco logoMoldcoSeed$8MSep 2025
    Castelion logoCastelionSeries B$350MJul 2025
    Remedy logoRemedySeed—Apr 2025
    Castelion logoCastelionSeries A$70MJan 2025
    EARTH AI logoEARTH AISeries B$20MJan 2025
    Intramotev logoIntramotevSeries A$14.4MAug 2024
    Shinkei logoShinkeiSeed$6MApr 2024
    Atomos Space logoAtomos SpaceSeries A$16.2MJan 2023
    Atomos logoAtomosSeries A$16.2MJan 2023
    Faeth Therapeutics logoFaeth TherapeuticsSeries A$47MJun 2022
    Venus Aerospace logoVenus AerospaceSeries A$20MApr 2022
    Faeth Therapeutics logoFaeth TherapeuticsSeed$20MJan 2022
    Atomos logoAtomosUnknown$5MJan 2022
    Atomos Space logoAtomos SpaceUnknown$5MJan 2022
    Tiamat Sciences logoTiamat SciencesSeries A$3MJan 2022
    Tiamat logoTiamatSeries A—Jan 2022
    Nabla Bio logoNabla BioSeed$11MDec 2021
    Nabla logoNablaSeed$11MDec 2021
    Tiamat Sciences logoTiamat SciencesSeed$3MNov 2021
    Page 1 of 3

    Top Co-Investors

    Last updated: 20 October 2026